MAR 27, 2019 12:00 PM PDT

Controlling Terpenes and Cannabinoids in Flower and Extract

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Founder & CEO, Complex Biotech Discovery Ventures
    Biography
      Dr. Roggen's latest project, Complex Biotech Discovery Ventures, a fundamental research laboratory and CRO of the cannabis industry. His research interests lie in the metabolite composition and behavior throughout the production cycle, SFE process optimization, and development of innovative therapeutic formulations. Dr. Roggen received his master in science degree from Imperial College, London, UK in 2008. He then pursued his graduate degree is organic chemistry at the Federal Institute of Technology in Zürich (ETHZ), where he received his PhD in 2012. He then was awarded an DAAD postdoctoral fellowship to pursue further training in physical organic chemistry at The Scripps Research Institute in La Jolla from 2013-2014. He then entered the cannabis industry, at first as laboratory director for Davinci Laboratories of California, an analytical laboratory from 2014 to 2016. In 2016 he moved into an executive position overseeing production, R&D and process optimization for OutCo, a cannabis manufacturer. Dr. Markus Roggen is also a trusted advisor and mentor for multiple startups, startup accelerators and organizations. Positions include advisory positions at Bloom Automation, a cannabis robotics company, Redfield Proctor, a waste management company, and former co-chair of the NCIA Scientific Advisory Committee.

    Abstract

    The cannabis industry has realized that not just one or two compounds of the plant are important for a variety of medical indications. A plethora of metabolites, e.g. terpenes, flavonoids and cannabinoids, give rise to the desired effects. Such chemical makeups are not only dictated by the strain/cultivar, but also influenced by grow methods, drying and curing, and also the extraction method. Unfortunately, it is mostly overlooked how these processes lead to high quality, reliable products. This talk will discuss our latest findings on how to control the molecular makeup throughout the production pipeline.

    Learning Objectives: 

    1. The audience will learn about the changes that happen to cannabis and its bioactive molecules during different production stages.
    2. The audience will learn about ways of how to control such changes and even consciously manipulate molecular profiles.


    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    Loading Comments...
    Show Resources
    Attendees
    • See more